GGrantIndex
← Search

Plan to Enhance Diversity

$248,683P30FY2024CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

The overarching goal for Roswell Park's Plan to Enhance Diversity (PED) component is to promote and sustain inclusive training, hiring, and career development processes using diversity, equity, and inclusion (DEI) best practices. We will achieve this through purposeful and intentional assessment, program planning, resource allocation, and evaluation activities to optimize and enhance the center's DEI infrastructure. Roswell Park leadership has committed to a purpose driven strategic partnership approach to align and sustain DEI activities and best practices across the organization. Broadly, our PED plan will enhance and expand infrastructure to increase participation of women and individuals from groups historically underrepresented in the research workforce, which includes trainees, faculty, research staff, and center leadership. Our specific aims cover the priority areas identified in our PED logic model and address structural factors (e.g., cancer center infrastructure and environment) and institutional level mechanisms (e.g., workforce development, pipeline programs, faculty recruitment and retention) in a complementary manner. The PED team is collaborating with organizational partners to implement DEI best practice strategies to mitigate bias and improve climate across the educational and professional continuum extending to cancer care delivery. Roswell Park's Plan to Enhance Diversity is driven by three aims: 1) Enhance diversity in faculty and center leadership; 2) Enhance the educational, mentoring, and training infrastructure to support participation from diverse and underrepresented populations; and 3) Develop and implement criteria for monitoring and evaluating progress in diversity to support sustainability of diversity, equity, and inclusion best practices. This PED component is led by Elisa M. Rodriguez, PhD, MS, serving as the inaugural Associate Director (AD) of DEI since August 2022. Dr. Rodriguez is an Associate Professor, Population Sciences program member, and former Chief Diversity and Equity Officer for Faculty, which provided valuable insight for the AD of DEI role. The DEI office and PED component work together to support a holistic DEI approach across the cancer center in collaboration with staff affiliated with Cancer Research Training and Education Coordination (CRTEC) and the Office of Community Outreach and Engagement (COE). PED partners with COE to include the viewpoints of diverse community stakeholders through multiple feedback pathways to ensure our DEI efforts are inclusive and responsive to the needs and values of the catchment area and beyond. PED, COE, and CRTEC are and will continue to be synergetic in their approaches to ensure alignment and integration of best practices, including routinely sharing and reviewing qualitative and quantitative data to inform prescriptive activities that address opportunities to enhance PED, COE, and CRTEC cancer center operations.

View original record on NIH RePORTER →